Telomere aggregates in hepatitis C patients

Cancer Investigation

Volumn 27, Issue 6, 2009, Pages 650-654

  Amiel, A ^a,b   Fejgin, M D ^a,c   Goldberg Bittman, L ^a,b   Sharoni, R ^a,c   Hadary, R ^a,c   Kitay Cohen, Y ^a,c  

^a MEIR MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cancer genetics; Detection Diagnosis; Liver and biliary system

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE MICROSCOPY; HEPATITIS C; HUMAN; LEUKOCYTE; PRIORITY JOURNAL; TELOMERE; CELL CULTURE; COMPARATIVE STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; MIDDLE AGED; NONHODGKIN LYMPHOMA; TREATMENT OUTCOME; ULTRASTRUCTURE; VIROLOGY; VIRUS CELL TRANSFORMATION;

ANTIVIRUS AGENT;

ANTIVIRAL AGENTS; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; HEPATITIS C, CHRONIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKOCYTES; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; TELOMERE; TREATMENT OUTCOME;

EID: 67649967887     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802350806     Document Type: Article

References (33)

1. Kim, N.W.; Piatyszek, M.A.; Prowse, K.R.; et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2015.
2. Shay, J.W.; Bacchetti, S.A. A survey to telomerase activity in human cancer. Eur J Cancer 1997, 33, 787-791. (Pubitemid 27239490)
3. Counter, C.M.; Avilion, A.A.; LeFeuvre, C.E.; et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992, 11, 1921-1929.
4. Greider, C.W. Mammalian telomere dynamics: healing, fragmentation shortening, and stabilization. Curr Opin Genet Dev 1994, 4, 203-211.
5. de Lange, T.; Shiue, L.; Myers, R.M.; et al. Structure and variability of human chromosome ends. Mol Cell Biol 1990, 10, 518-527. (Pubitemid 20034458)
6. Dynek, J.N.; Smith, S. Resolution of sister telomere association is required for progression through mitosis. Science 2004, 304, 97-100. (Pubitemid 38451464)
7. Pathak, S.; Multani, A.S. Aneuploidy, stem cells and cancer. Cancer Cell Struct Carcinog Genom Instab 2006, 96, 49-64.
8. Chuang, T.C.Y.; Moshir, S.; Garini, Y.; et al. The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol 2004, 2, 12.
9. Louis, S.F.; Vermoten, B.J.; Garini, Y.; et al. C-myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci USA 2005, 102, 9613-9618.
10. DePinho, R.A.; Polyak, K. Cancer chromosomes in crisis. Nat Genet 2004, 36, 932-934.
11. Artandi, S.E.; Chung, S.; Lee, S.L.; et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406, 641-644.
12. Murnane, J.P.; Sabatier, L. Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bio Essays 2004, 26, 1164-1174. (Pubitemid 39536612)
13. Muller, H.J. The remaking of chromosomes. Collect Net 1938, 13, 181-198.
14. McClintock, B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941, 26, 234-282.
15. McClintock, B. The fusion of broken ends of chromosomes following nuclear fusion. Proc Natl Acad Sci USA 1942, 28, 458-463.
16. Mai, S.; Garini, Y. The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 2006, 97, 904-915.
17. Goldberg-Bittman, L.; Kitay-Cohen, Y.; Quitt, M.; Hadary, R.; Fejgin, M.D.; Yukla, M.; Amiel, A. Telomere aggregates in non- Hodgkin's lymphoma (NHL) patients at different disease stages. Cancer Genet Cytogenet 2008, in press.
18. Monteverde, A.; Rivano, M.T.; Allegra, G.C.; et al. Essential mixed cryoglobulinemia type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acata Haematol 1988, 79, 20-25.
19. Coleman, W.B. Mechanisms of human hepatocarcinogenesis. Curr Mol Med 2003, 3, 573-588.
20. Sekoguchi, S.; Nakajima, T.; Moriguchi, M.; et al. Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis. C.J. Gastoenterol Hepatol 2007, 22, 182-190.
21. Goldberg-Bittman, L.; Kitay-Cohen, Y.; Hadari, R.; et al. Random aneuploidy in chronic hepatitis C patients and in remission. Cancer Genet Cytogenet 2008, 180, 20-23.
22. Smirnova, I.; Aksenov, N.D.; Kashuba, E.V.; et al. Hepatitis C virus core protein transforms murine fibroblasts by promoting genomic instability. Cell Oncol 2006, 28, 177-190.
23. Mise, K.; Tashiro, S.; Yogita, S.; et al. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Clin Cancer Res 1998, 4, 1475-1482.
24. Kato, A.; Kubo, K.; Kurokawa, F.; et al. Numerical aberrations of chromosomes 16, 17, and 18 in hepatocellular carcinoma: a FISH and FCM analysis of 20 cases. Dig Dis Sci 1998, 43, 1-7. (Pubitemid 28081633)
25. Terris, B.; Ingster, O.; Rubbia, L.; et al. Interphase cytogenetic analysis reveals numerical chromosome aberrations in large liver cell dysplasia. J Hepatol 1997, 27, 313-319.
26. Amiel, A.; Goldzak, G.; Gaber, E.; et al. Random aneuploidy and telomere capture in chronic lymphocytic leukemia and chronic myeloid leukemia patients. Cancer Genet Cytogenet 2005, 163, 12-16.
27. Amiel, A.; Gronich, N.; Yukla, M.; et al. Random aneuploidy in neoplastic and preneoplastic diseases, multiple myeloma, and monoclonal gammopathy. Cancer Genet Cytogenet 2005, 162, 78-81.
28. Amiel, A.; Yukla, M.; Gaber, E.; et al. Random aneuploidy in CML patients at diagnosis and under imatinib treatment. Cancer Genet Cytogenet 2006, 168, 120-123.
29. Amiel, A.; Elis, A.; Blumenthal, D.; et al. Modified order of allelic replication in lymphoma patients at different disease stages. Cancer Genet Cytogenet 2001, 125, 156-160.
30. Amiel, A.; Kitay-Cohen, Y.; Fejgin, M.D.; et al. Replication status as a marker for predisposition for lymphoma in patients with chronic hepatitis C with and without cryoglobulinemia. Exp Hematol 2000, 28, 156-160.
31. Tokita, H.; Fukui, H.; Tanaka, A.; et al. Risk factors for the development of hepatocellular carcinoma among patients with chronic hepatitis C who achieved a sustained virological response to interferon therapy. J Gastroentero Hepato 2005, 20, 752-758. (Pubitemid 40733371)
32. Chavalitdhamrong, D.; Tanwandee, T. Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment. World J Gastroenterol 2006, 12, 5532-5535. (Pubitemid 44501815)
33. Tanaka, A.; Uegaki, S.; Kurihara, H.; et al. Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C. World J Gastroenterol 2007, 13, 5180-5187.